Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06077942 · ClinicalTrials.gov registry record
FX Shoulder Solutions Retrospective / Prospective Clinical Study
A clinical trial of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, sponsored by FX Shoulder Solutions.
- Recruiting
- Registry status
- 600
- Enrollment target
- 2
- Study locations
NCT06077942: Recruiting study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, sponsored by FX Shoulder Solutions.
NCT06077942 is a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders that is actively recruiting participants, run by FX Shoulder Solutions. The registered enrollment target is 600 participants, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06077942, a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, is actively recruiting participants, sponsored by FX Shoulder Solutions.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
Primary Outcome
* Adjusted Constant Score \> 70 * No continuous radiolucency or device migration/subsidence * No revision surgery or removal * No serious device related adverse event The Study will continue to follow patients prospectively to 10 years postoperative to track survivorship.
Conditions Studied
Interventions
- DEVICE FX Artificial Shoulder Prosthesis
Study Locations (2)
Arizona
- OrthoArizona - Gilbert
Florida
- Advanced Orthopedics Institute - The Villages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2032-12-30 |
What NCT06077942 shows while recruiting
NCT06077942 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher).
The record links to 3 conditions, with Osteoarthritis Shoulder appearing as the primary indexed condition, and to 1 intervention - of which FX Artificial Shoulder Prosthesis is the first listed.
NCT06077942 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT06077942 about?
NCT06077942 is a clinical study titled "FX Shoulder Solutions Retrospective / Prospective Clinical Study". Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
What is the current status of trial NCT06077942?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2022-12-06. Estimated completion is 2032-12-30.
What conditions does trial NCT06077942 study?
This clinical trial studies the following conditions: Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Fracture, Shoulder.
What interventions are being tested in trial NCT06077942?
The interventions under investigation include: FX Artificial Shoulder Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT06077942?
This trial is sponsored by FX Shoulder Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06077942 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06077942's enrollment target sits among peer trials
600 2nd of 8 higher than 6 of 8 other Osteoarthritis Shoulder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis Shoulder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
-
FX Shoulder Prospective Clinical Study
RECRUITING
-
Embo Registry; National Registry for Artery Embolization
RECRUITING
-
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
RECRUITING · NA
-
Perform Humeral System Study
RECRUITING
-
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI